D008130Chemicals & DrugsD02.654.692.440D02.948.594.4408260.995344Lomustineprns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson0.4006410.03568238research area of0.2211560.015189425subject area forMei-YinPolley2mF5BK0ZHPX5k2lgLlPt+2z5/syyp7BaZQ==Mei-Yin Polley41.7886000000000087.598699999999993904Polley, Mei-YinAssociate Professor1737376Mitchell RB, Moschel RC, Dolan MECancer researchEffect of O6-benzylguanine on the sensitivity of human tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea and on DNA interstrand cross-link formation. Cancer Res. 1992 Mar 01; 52(5):1171-5.Cancer Res1992-03-01T00:00:001992Effect of O6-benzylguanine on the sensitivity of human tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea and on DNA interstrand cross-link formation.Medicine-Hematology and OncologyNeurological Surgery21997132Yothers G, Sargent DJ, Wolmark N, Goldberg RM, O'Connell MJ, Benedetti JK, Saltz LB, Dignam JJ, Blackstock AW, ACCENT Collaborative GroupJournal of the National Cancer InstituteOutcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials. J Natl Cancer Inst. 2011 Oct 19; 103(20):1498-506.J Natl Cancer Inst2011-10-12T00:00:002011Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.Public Health Scienceshttp://pbhs.uchicago.eduPHS graduate programhttp://www.pgrn.org/pgx-of-chemotherapeutic-toxicities.htmlMy Lab Objectiveshttps://health.uchicago.edu/Department of Public Health Scienceshttps://www.uchicagomedicine.org/find-a-physician/physician/peter-warnkeLearn more about this provider...University of ChicagoNinaPaleologosNina Paleologos41.78927490000000-87.601250000000001234Paleologos, NinaHarvey M.GolombHarvey M. Golomb41.78927490000000-87.601250000000002105Golomb, Harvey M.ProfessorPeter ChristianWarnkex3VoGa8eHMzMknJtY0fp/Cv/+94=Peter Christian Warnke41.78927490000000-87.601250000000002372Warnke, Peter ChristianProfessorMary EileenDolan2mdtBK0UF8zMknJtY0fp/Cv/+94=Mary Eileen Dolan41.78927490000000-87.601250000000002594Dolan, Mary EileenProfessor35731991Lassman AB, Hoang-Xuan K, Polley MC, Brandes AA, Cairncross JG, Kros JM, Ashby LS, Taphoorn MJB, Souhami L, Dinjens WNM, Laack NN, Kouwenhoven MCM, Fink KL, French PJ, Macdonald DR, Lacombe D, Won M, Gorlia T, Mehta MP, van den Bent MJJournal of clinical oncology : official journal of the American Society of Clinical OncologyJoint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors. J Clin Oncol. 2022 08 10; 40(23):2539-2545.J Clin Oncol2022-06-22T00:00:002022Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors.true1true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professor27006176Jakacki RI, Cohen KJ, Buxton A, Krailo MD, Burger PC, Rosenblum MK, Brat DJ, Hamilton RL, Eckel SP, Zhou T, Lavey RS, Pollack IFNeuro-oncologyPhase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study. Neuro Oncol. 2016 10; 18(10):1442-50.Neuro Oncol2016-03-22T00:00:002016Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study.23180870Wang M, Dignam JJ, Zhang QE, DeGroot JF, Mehta MP, Hunsberger SClinical trials (London, England)Integrated phase II/III clinical trials in oncology: a case study. Clin Trials. 2012 Dec; 9(6):741-7.Clin Trials2012-11-22T00:00:002012Integrated phase II/III clinical trials in oncology: a case study.